118 related articles for article (PubMed ID: 20148989)
1. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
[TBL] [Abstract][Full Text] [Related]
2. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells in patients with urothelial cancer.
Gallagher DJ; Milowsky MI; Ishill N; Trout A; Boyle MG; Riches J; Fleisher M; Bajorin DF
Ann Oncol; 2009 Feb; 20(2):305-8. PubMed ID: 18836088
[TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K
Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods.
Königsberg R; Gneist M; Jahn-Kuch D; Pfeiler G; Hager G; Hudec M; Dittrich C; Zeillinger R
Cancer Lett; 2010 Jul; 293(1):117-23. PubMed ID: 20167419
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
[TBL] [Abstract][Full Text] [Related]
10. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
Takao M; Takeda K
Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706
[TBL] [Abstract][Full Text] [Related]
11. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
12. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
13. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
Danila DC; Heller G; Gignac GA; Gonzalez-Espinoza R; Anand A; Tanaka E; Lilja H; Schwartz L; Larson S; Fleisher M; Scher HI
Clin Cancer Res; 2007 Dec; 13(23):7053-8. PubMed ID: 18056182
[TBL] [Abstract][Full Text] [Related]
15. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
Dawood S; Broglio K; Valero V; Reuben J; Handy B; Islam R; Jackson S; Hortobagyi GN; Fritsche H; Cristofanilli M
Cancer; 2008 Nov; 113(9):2422-30. PubMed ID: 18785255
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells.
Nini A; Hoffmann MJ; Lampignano R; Große Siemer R; van Dalum G; Szarvas T; Cotarelo CL; Schulz WA; Niederacher D; Neubauer H; Stoecklein NH; Niegisch G
Cytometry B Clin Cytom; 2020 Jul; 98(4):355-367. PubMed ID: 32212383
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Balic M; Dandachi N; Hofmann G; Samonigg H; Loibner H; Obwaller A; van der Kooi A; Tibbe AG; Doyle GV; Terstappen LW; Bauernhofer T
Cytometry B Clin Cytom; 2005 Nov; 68(1):25-30. PubMed ID: 16142788
[TBL] [Abstract][Full Text] [Related]
19. Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.
Lin CC; Hsu CH; Huang CY; Cheng AL; Chen J; Vogelzang NJ; Pu YS
Cancer; 2006 Mar; 106(6):1269-75. PubMed ID: 16470604
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
